Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
237,143
-
Share change
-
-52,503
-
Total reported value
-
$235,867
-
Price per share
-
$1.00
-
Number of holders
-
10
-
Value change
-
-$50,264
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q3 2023
As of 30 Sep 2023,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
237,143 shares.
The largest 10 holders included
MORGAN STANLEY, ACADIAN ASSET MANAGEMENT LLC, Virtu Financial LLC, BNP PARIBAS ARBITRAGE, SNC, RHUMBLINE ADVISERS, NewEdge Advisors, LLC, BANK OF AMERICA CORP /DE/, Allworth Financial LP, Steward Partners Investment Advisory, LLC, and AdvisorNet Financial, Inc.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.